Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study

CONCLUSIONS: The highest rate of cirAEs and subsequent survival benefits were observed in cutaneous malignancies treated with ICIs. This study improves our understanding of patients who are at highest risk of developing cirAEs and would, therefore, benefit from appropriate counseling and closer monitoring by their oncologists and dermatologists throughout their ICI therapy. Limitations include its retrospective nature and cohort from one geography.PMID:38366637 | DOI:10.1093/bjd/ljae053

Source: The British Journal of Dermatology - February 17, 2024 Category: Dermatology Authors: Guihong Wan Sara Khattab Bonnie W Leung Shijia Zhang Nga Nguyen Matthew Tran Chuck Lin Crystal Chang Nora Alexander Ruple Jairath Jordan Phillipps Kimberly Tang Ahmad Rajeh Leyre Zubiri Steven T Chen Shadmehr Demehri Kun-Hsing Yu Alexander Gusev Shawn G K Source Type: research